“…Each RNA is transcribed from its own promoter and terminates at a common polyadenylation site (16,52,72). The structure and function of the four HBV promoters have been quite extensively characterized, and it is apparent that liver-specific expression from the enhancer 1/X gene, nucleocapsid, and large surface antigen promoters results from the combinatorial action of multiple liver-enriched transcription factors, including C/EBP, HNF1, HNF3, and HNF4, binding to the regulatory sequence elements of these promoters (5,9,12,17,20,27,35,36,44,47,50,57,75,80). The reason why transcription of the major surface antigen RNA is restricted to hepatocytes in vivo is currently unclear, as the identified regulatory sequence elements of the major surface antigen promoter bind ubiquitous transcription factors (51,61).…”